Patents by Inventor Mark Anderson

Mark Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8043616
    Abstract: Mammalian sRAGE mimetibody polypeptides and nucleic acids are disclosed. Methods of utilizing the polypeptides to reduce or inhibit the binding of RAGE and its ligands and to treat RAGE-related diseases are also disclosed.
    Type: Grant
    Filed: July 17, 2008
    Date of Patent: October 25, 2011
    Assignee: Centocor, Inc.
    Inventors: Glenn Mark Anderson, Robert Jordan, Kristen Picha
  • Patent number: 8016232
    Abstract: Methods and apparatus are provided controlling aircraft cabin pressure, and more specifically engine bleed air manifold pressure, during aircraft descent. An aircraft engine bleed air manifold control pressure setpoint is to either a descent pressure setpoint or a cruise pressure setpoint by determining a rotational speed of an aircraft engine component, determining a component speed setpoint value, and determining aircraft vertical speed. The engine bleed air manifold control pressure setpoint is set to the descent pressure setpoint if either the determined rotational speed of the aircraft engine component is below the component speed setpoint value or the aircraft vertical speed is less than a predetermined vertical speed value.
    Type: Grant
    Filed: May 29, 2008
    Date of Patent: September 13, 2011
    Assignee: Honeywell International Inc.
    Inventors: Peter Mark Anderson, Karen Hosler, Greg Chapman, Wai Pak Wong
  • Publication number: 20110213983
    Abstract: The invention relates to an authentication and/or energy auditing system for a plug-in electric drive vehicle. A first device connects to a first power apparatus and establishes an electrical power path between the first and a remote device. The latter is connectable to a second power apparatus. The authentication system preferably includes a powerline transceiver to receive a request containing an identifier from the remote device over the power path. Control means controls operation of the first device and responds to the request to initiate an authentication process to determine whether or not the remote device is authentic and authorised to exchange power with the first device, and to activate a control switch to electrically connect the first device to the first power apparatus only upon an authentic and authorised determination.
    Type: Application
    Filed: July 21, 2009
    Publication date: September 1, 2011
    Inventors: Paul Staugaitis, Mark Anderson
  • Patent number: 8010552
    Abstract: A system and method for updating a filtering system which controls access to a website/page between a local area network (LAN) and an Internet. The LAN includes an Internet gateway system coupled to a workstation and configured to receive a URL request. The system controls access to the website/page associated with the URL based on one or more categories that are associated with the URL. The Internet gateway system can determine the category that is associated with the URL by referencing a master database or requesting the category from a database factory. The database factory can receive URLs from multiple Internet gateway systems. The database factory determines whether the identifier was previously categorized by the database factory and provides the category to the Internet gateway system. Once the Internet gateway system has the category, it applies rules associated with the category and user to filter access to the requested website/page.
    Type: Grant
    Filed: January 18, 2007
    Date of Patent: August 30, 2011
    Assignee: Websense, Inc.
    Inventors: Harold Kester, Dan Ruskin, Chris Lee, Mark Anderson
  • Publication number: 20110174309
    Abstract: An aspiration and resuscitation system which is useable to perform aspiration and/or resuscitation procedures on living beings, particularly small animals, and most particularly newborn small animals such as puppies and kittens. The system includes an aspirator and a resuscitator. Each includes a separable pump and animal interface mask. Further disclosed are aspiration and resuscitation methods using the disclosed apparatus.
    Type: Application
    Filed: January 19, 2011
    Publication date: July 21, 2011
    Inventor: Mark Anderson
  • Publication number: 20110099921
    Abstract: A modular display booth system is disclosed. The booth comprises walls, inserts, and toolless fasteners. The system is configured for efficient assembly and disassembly. The modular display booth system may be stored entirely on a single dolly for ease of transportation, coordination, and in warehouse alterations.
    Type: Application
    Filed: October 29, 2010
    Publication date: May 5, 2011
    Applicant: GES EXPOSITION SERVICES, INC.
    Inventors: Thomas Fitzgerald, Andrew Clark, Leonard Izzo, J.L. Lynch, Ivan Mitchell, Mark Anderson
  • Publication number: 20110079453
    Abstract: Methods and apparatus may augment the utility of an electrically powered vehicle. A first electric motor (110a or 110b) may be provided with a first effective gear ratio, a second electric motor (111a or 111b) may be provided with a second effective gear ratio, and additional electric motors may be provided additional effective gear ratios. An electrically powered vehicle may be differentially powered by said electric motors at said different effective gear ratios. A transdisciplinary electrical diagnostic processor (440) may process electrically recondite operation parameters of one or more electrical components to provide transdisciplinary diagnostic output to a user. A standardized modular interface (540) supported on a trailer chassis (510) may be configured to accept multipurposed modular interchangeable trailer tops (560) at an interchange position (550) of said trailer chassis (510). A hand actuated accessory mount may be provided with a quick release interface (322).
    Type: Application
    Filed: December 10, 2010
    Publication date: April 7, 2011
    Applicant: EV-IP, LLC
    Inventors: Mark E. Wanger, Mark A. Anderson
  • Publication number: 20100322984
    Abstract: The present invention describes oral care compositions comprising certain surface-coated inorganic oxides and their use for treating dentine hypersensitivity.
    Type: Application
    Filed: January 29, 2009
    Publication date: December 23, 2010
    Inventors: Gareth David Rees, Charles Richard Parkinson, Robert Mark Anderson
  • Patent number: 7855315
    Abstract: A continuous sheet having a combination of acidic and basic water-absorbing resin particles that are essentially not neutralized and can be continuously manufactured on conventional papermaking apparatus, using a wet, dry, or wet-dry process to manufacture a water-absorbent sheet-like substrate containing 50%-100% by weight of the combination of acidic and basic water-absorbent particles is disclosed.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: December 21, 2010
    Inventors: Michael A. Mitchell, Mark Anderson, Thomas W. Beihoffer
  • Patent number: 7809857
    Abstract: A method and a system perform geolocation activities relating to a network address. A database of network addresses, and associated geographic locations, is maintained. A query, including a network address, is received against the database for a geographic location associated with the network address. Information, concerning the query received against the database, is logged. Geolocation activities relating to at least the network address are modified based on the logged information.
    Type: Grant
    Filed: October 14, 2003
    Date of Patent: October 5, 2010
    Assignee: Quova, Inc.
    Inventors: Mark Anderson, Ajay Bansal, Brad Doctor, George Hadjiyiannis, Christopher Herringshaw, Eli E. Karplus, Derald Muniz
  • Publication number: 20100227838
    Abstract: The present disclosure relates to a combination of therapeutic agents for use in treating a patient a subject suffering from cancer. In addition, the present disclosure also relates to diagnostic assays useful in classification of patients for treatment with one or more therapeutic agents.
    Type: Application
    Filed: December 4, 2009
    Publication date: September 9, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Omar Jameel Shah, Yu Shen, Xiaoyu Lin, Mark Anderson, Xiaoli Huang, Junling Li, Leiming Li
  • Patent number: 7770787
    Abstract: A credential communication device and method adapted to transmit and receive data, including means to process said data in order to effect credential verification and trusted mutual recognition between the device and a second credential communication device, without reference to a third party, further including at least one proximity conductor adapted to transfer at least some data only when in such physical proximity to a second credential communication device as to effectively exclude the possibility of third party involvement in the transaction.
    Type: Grant
    Filed: June 10, 2004
    Date of Patent: August 10, 2010
    Assignee: The Commonwealth of Australia
    Inventor: Mark Anderson
  • Patent number: 7642651
    Abstract: An integrated circuit interconnect is fabricated by using a mask to form a via in an insulating layer for a conductive plug. After the plug is formed in the via, a thin (e.g., <100 nm) isolation layer is deposited over the resulting structure. An opening is created in the isolation layer by using the same mask at a different radiation exposure level to make the opening more narrow than the underlying plug. A conductive line is then formed which makes electrical contact with the plug through the opening in the isolation layer. By vertically separating and electrically isolating the conductive plug from adjacent conductive lines, the isolation layer advantageously reduces the likelihood of an undesired electrical short occurring between the conductive plug and a nearby conductive line.
    Type: Grant
    Filed: November 16, 2006
    Date of Patent: January 5, 2010
    Assignee: Micron Technology, Inc.
    Inventors: Todd Albertson, Darin Miller, Mark Anderson
  • Patent number: 7632815
    Abstract: The present invention provides a method for treating structural heart disease in a subject, comprising administering an effective amount of an inhibitor of CaMKII to the subject, whereby the administration of the inhibitor treats the structural heart disease in the subject. Also provided are transgenic animal models for treating structural heart disease. Further provided is a means of screening for a compound that can treat structural heart disease.
    Type: Grant
    Filed: November 13, 2007
    Date of Patent: December 15, 2009
    Assignee: Vanderbilt University
    Inventor: Mark Anderson
  • Publication number: 20090298407
    Abstract: Methods and apparatus are provided controlling aircraft cabin pressure, and more specifically engine bleed air manifold pressure, during aircraft descent. An aircraft engine bleed air manifold control pressure setpoint is to either a descent pressure setpoint or a cruise pressure setpoint by determining a rotational speed of an aircraft engine component, determining a component speed setpoint value, and determining aircraft vertical speed. The engine bleed air manifold control pressure setpoint is set to the descent pressure setpoint if either the determined rotational speed of the aircraft engine component is below the component speed setpoint value or the aircraft vertical speed is less than a predetermined vertical speed value.
    Type: Application
    Filed: May 29, 2008
    Publication date: December 3, 2009
    Applicant: Honeywell International Inc.
    Inventors: Peter Mark Anderson, Karen Hosler, Greg Chapman, Wai Pak Wong
  • Patent number: 7605235
    Abstract: Isolated anti-tissue factor antibodies, immunoglobulins, cleavage products and other specified portions and variants thereof having enhanced ADCC activity, as well as anti-tissue factor antibody compositions, encoding or complementary nucleic acids, vectors, host cells, compositions, formulations, devices, transgenic animals, transgenic plants, and methods of making and using thereof. The antibodies of the invention bind human tissue factor and demonstrate enhanced ADCC activity. Accordingly, the antibodies can be used in a variety of methods for diagnosing, treating, and/or preventing diseases involving tissue factor, where enhanced ADCC activity is desirable such as cancer.
    Type: Grant
    Filed: December 13, 2004
    Date of Patent: October 20, 2009
    Assignee: Centocor, Inc.
    Inventors: G. Mark Anderson, Bernard Scallon, Michael Naso, Ann Cai, Cam Ngo
  • Publication number: 20090232734
    Abstract: Isolated anti-tissue factor antibodies, immunoglobulins, cleavage products and other specified portions and variants thereof having enhanced ADCC activity, as well as anti-tissue factor antibody compositions, encoding or complementary nucleic acids, vectors, host cells, compositions, formulations, devices, transgenic animals, transgenic plants, and methods of making and using thereof. The antibodies of the invention bind human tissue factor and demonstrate enhanced ADCC activity. Accordingly, the antibodies can be used in a variety of methods for diagnosing, treating, and/or preventing diseases involving tissue factor, where enhanced ADCC activity is desirable such as cancer.
    Type: Application
    Filed: March 27, 2009
    Publication date: September 17, 2009
    Inventors: G. Mark Anderson, Bernard Scallon, Michael Naso, Ann Cai, Cam Ngo
  • Publication number: 20090197241
    Abstract: Methods and systems of maintaining, evaluating, and providing therapy to a lung ex vivo. The methods and systems involve positioning the lung in an ex vivo perfusion circuit; circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface; and ventilating the lung by flowing a ventilation gas through a tracheal interface. Maintaining the lung for extended periods involves causing the lung to rebreath a captive volume of air, and reaching an equilibrium state between the perfusion fluid and the ventilation gas. Evaluating the gas exchange capability of the lung involves deoxygenating the perfusion fluid and measuring a time taken to reoxygenate the perfusion fluid by ventilating the lung with an oxygenation gas.
    Type: Application
    Filed: April 8, 2008
    Publication date: August 6, 2009
    Inventors: Robert Fishman, Robert Havener, Ihab Abdel Fattah, Anas Abdelazim, Scott Newell, Tom Bishop, Tamer Khayal, Stanley Kyi, Ron Taylor, Doug Harriott, Matthew De Remer, Paul Murray, John Sullivan, Mark Anderson, Richard Bringham, Michael Van Driel, Waleed Hassanein
  • Publication number: 20090197325
    Abstract: Methods and systems of maintaining, evaluating, and providing therapy to a lung ex vivo. The methods and systems involve positioning the lung in an ex vivo perfusion circuit; circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface; and ventilating the lung by flowing a ventilation gas through a tracheal interface. Maintaining the lung for extended periods involves causing the lung to rebreath a captive volume of air, and reaching an equilibrium state between the perfusion fluid and the ventilation gas. Evaluating the gas exchange capability of the lung involves deoxygenating the perfusion fluid and measuring a time taken to reoxygenate the perfusion fluid by ventilating the lung with an oxygenation gas.
    Type: Application
    Filed: April 8, 2008
    Publication date: August 6, 2009
    Inventors: Robert FISHMAN, Robert HAVENER, Ihab Abdel FATTAH, Anas ABDELAZIM, Scott NEWELL, Tom BISHOP, Tamer KHAYAL, Stanley KYI, Ron TAYLOR, Doug HARRIOTT, Matthew DE REMER, Paul MURRAY, John SULLIVAN, Mark ANDERSON, Richard BRINGHAM, Michael VAN DRIEL, Waleed Hassanein
  • Publication number: 20090197324
    Abstract: Methods and systems of maintaining, evaluating, and providing therapy to a lung ex vivo. The methods and systems involve positioning the lung in an ex vivo perfusion circuit; circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface; and ventilating the lung by flowing a ventilation gas through a tracheal interface. Maintaining the lung for extended periods involves causing the lung to rebreath a captive volume of air, and reaching an equilibrium state between the perfusion fluid and the ventilation gas. Evaluating the gas exchange capability of the lung involves deoxygenating the perfusion fluid and measuring a time taken to reoxygenate the perfusion fluid by ventilating the lung with an oxygenation gas.
    Type: Application
    Filed: April 8, 2008
    Publication date: August 6, 2009
    Inventors: Robert FISHMAN, Robert HAVENER, Ihab Abdel FATTAH, Anas ABDELAZIM, Scott NEWELL, Tom BISHOP, Tamer KHAYAL, Stanley KYI, Ron TAYLOR, Doug HARRIOTT, Matthew DE REMER, Paul MURRAY, John SULLIVAN, Mark ANDERSON, Richard BRINGHAM, Michael VAN DRIEL, Waleed Hassanein